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Background: Aetiology of childhood leukaemia and childhood neoplasm is poorly understood. Information on the
prevalence of risk factors in the childhood population is limited. SETIL is a population based case–control study on
childhood leukaemia, conducted with two companion studies on non-Hodgkin Lymphoma (NHL) and neuroblastoma.
The study relies on questionnaire interviews and 50 Hz magnetic field (ELF-MF) indoor measurements. This paper
discusses the SETIL study design and includes descriptive information.
Methods: The study was carried out in 14 Italian regions (78.3% of Italian population aged 0–10). It included leukaemia,
NHL and neuroblastoma cases incident in 0–10 year olds in 1998–2001, registered by the Italian Association of Paediatric
Haematology and Oncology (AIEOP) (accrual over 95% of estimated incidence). Two controls for each leukaemia case
were randomly sampled from the Local Health Authorities rolls, matched by gender, birthdate and residence. The same
controls were used in NHL and neuroblastoma studies. Parents were interviewed at home on: physical agents (ELF-MF
and ionizing radiation), chemicals (smoking, solvents, traffic, insecticides), occupation, medical and personal history of
children and parents, infectious diseases, immunizations and associated factors. Occupational exposure was
collected using job specific modules. ELF-MF was measured in the main rooms (spot measurement) and close to
child’s bed (48 hours measurement).
Results: The study included: 683 leukaemia cases (87% ALL, 13% AnLL), 97 NHL, 155 neuroblastomas, and 1044
controls.
ELF-MF long term measurements were obtained for 61.1% of controls and 81.6% of leukaemia cases; 8.8% of
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controls were exposed at over 0.1 microTesla (μT), 3.5% and 2.1% at respectively over 0.2 and 0.3 μT. 25% of controls’
fathers had smoked over 10 cigarettes/day during the year of conception, varying according to education and region.
Maternal smoking was less common (71.4% did not smoke in pregnancy). Maternal passive smoking during pregnancy
was reported by 31.2% of controls; the child’s passive smoking for 28.6%.
Occupational exposure to solvents was estimated in 18.3% of controls’ fathers and 7.7% of mothers. Contact with
public was more frequent among mothers (36.1%) than fathers (23.4%).
Conclusions: SETIL represents a data source on exposure of Italian children to a broad array of potential carcinogenic
factors.
Keywords: Leukaemia, Non hogdkin lymphoma, Neuroblastoma, Epidemiology, Risk factorsBackground
Despite intensive research, the aetiology of childhood
neoplasms is still poorly known, even in the case of
frequent tumour types such as leukaemia, non-Hodgkin
Lymphomas (NHL) [1], and neuroblastoma [2]. Several
possible risk factors in the aetiology of childhood leukae-
mia, have been investigated including ionizing radiations
in pregnancy and after birth, Extremely Low-Frequency
magnetic fields (ELF-MF) and radiofrequency fields,
solvents, pesticides and other chemicals in the environ-
ment, infectious agents, immunizations and related fac-
tors. With the notable exception of ionizing radiation,
research results were not conclusive [1,3-5]. Strong sup-
port for an association between exposure to common
infections in early childhood (as estimated by day-care
attendance) and a reduced risk of acute lymphoblastic
leukaemia was provided by a recent meta-analysis of
14 case–control studies [6]. The aetiology of childhood
NHL is also poorly known, with the notable exception of
Burkitt lymphoma and EBV [3]. Epidemiological studies
on neuroblastoma also investigated a wide range of puta-
tive risk factors, including: socioeconomic conditions,
reproductive history, diagnostic x-rays, maternal expo-
sures in pregnancy, child’s characteristics, parental occu-
pation and related exposures, all with inconsistent results;
a protective effect was observed from breastfeeding and
folates in pregnancy [2].
From a population perspective, the prevalence of
exposed children is as important as the estimation of risk
since it is the basis for the correct estimation of popula-
tion attributable fraction and for preventive measures
under the framework of the precautionary principle.
A multicentre, population-based case–control epidemio-
logical study (SETIL - Studio Epidemiologico sui Tumori
Infantili Linfoemopoietici) was carried out in Italy to in-
vestigate risk factors for selected childhood neoplasms.
The main study focused on leukaemia and was accom-
panied by two smaller studies on NHL and neuroblast-
oma. The study relied on questionnaire based interviews
to parents of the study subjects and indoor measurements
of 50 Hz ELF-MF.Two methodological side studies, including subsets of
the main study, were performed on benzene [7] and on
gamma radiation exposure [8], in order to obtain infor-
mation on the occurrence of these exposures and their
correlation with ELF-MF.
The present paper illustrates the design of the SETIL
study, provides descriptive information on subjects in-
cluded in the main case–control study, and presents the




SETIL is a population based case–control study that was
carried out in 14 Italian regions (Piedmont, Liguria,
Lombardy, The Venetian Region, Friuli Venezia Giulia,
Emilia Romagna, Tuscany, Umbria, The Marches, The
Latium, Campania, Apulia, Sicily and Sardinia). Cases of
leukaemia, non-Hodgkin Lymphoma (NHL) and neuro-
blastoma in children aged 0–10 newly diagnosed be-
tween August 1998 and December 2001 (with minor
regional differences) were eligible for recruitment. The
network of paediatric oncology centres affiliated to the
Italian Association of Paediatric Haematology and On-
cology (AIEOP), i.e. the national network of the Italian
childhood cancer centres, was the source of cases.
AIEOP runs a nation wide database which records all
the new cases of paediatric cancer diagnosed or treated
in the network. Cases of paediatric neoplasm are recorded
on admission at any AIEOP unit using a common regis-
tration form which includes the patient’s personal iden-
tification data, as well as diagnosis and treatment
information. Each new patient is registered using elec-
tronic case report forms in the AIEOP “Mod.1.01 Regis-
try” web-based database hosted on the AIEOP website
(www.aieop.org) [9]. Estimated coverage of the AIEOP
registry in the period of the SETIL study was 94% for
leukaemia, 98% for neuroblastoma and 100% for NHL
[10]. The list of children eligible for the study was pro-
vided monthly by the AIEOP database at each Regional
Research Unit by means of authorized access to the
Magnani et al. Italian Journal of Pediatrics  (2014) 40:103 Page 3 of 13report area of the database. Only in the Lazio Region
a supplementary ad hoc search of eligible cases was
carried out through the hospital discharge files of the
main Rome paediatric hospital (not in the AIEOP
network at the time).
Controls were chosen at random from the population
residing in each region, using the Local Health Authority
(LHA) rolls. Two controls were randomly sampled for
each leukaemia case, matched by gender, date of birth
(±15 days) and LHA of residence. The resulting set of con-
trols was used as a pool in the studies on NHL and neuro-
blastoma, controlling analyses for age, gender and area of
residence. Non participating controls were not substituted.
Date of diagnosis was defined according to the clinical
information provided by AIEOP database with cases; for
controls a “pseudo diagnosis date” was set equal to the
date of diagnosis of the corresponding matched case.
Controls retained the assigned pseudo-diagnosis date for
the analyses for lymphoma and neuroblastoma subs-
tudies. Information was collected until child’s diagnosis
(or “pseudo diagnosis date” for matched controls). A
“reference date” was used to align the time of interest
when describing child’s typical day and use of (or expos-
ure to) electrical appliances and other exposures. It was
defined as one year before diagnosis (if case) or “pseudo
diagnosis date” (if controls). For children under 2 at
diagnosis, the reference date was corresponding to the
age of diagnosis divided by two.
Study presentation to index families
Regarding the cases, the study was explained to child’s
parents by the attending oncologist, usually after the
induction phase of treatment. Child’s parents were
contacted by the study staff only after the approval of
the attending oncologist. Families of children dying
before the study presentation were not excluded from
the study but the study presentation was delayed at
discretion of the attending clinician until the parents’
psychological conditions allowed for it.
Controls’ general practitioners (GP) were informed by
mail about the child’s enrolment in the study and were
asked to report their objections, if any. In such instances
the study local coordinator contacted the GP in order to
decide on the child’s inclusion; confirmed GP’s refusal
was accepted. GPs were welcome to inform the families
about the study but this was not required.
Interview
After medical approval, a research assistant mailed a
letter to child’s parents with detailed information on the
study and, a few days later, called them in order to verify
consent and arrange a suitable time for the interview. In-
terviewers were instructed to carry on several (at least 5)
telephone call attempts when needed, at different timesand on different days before declaring the subject as non
responder. Interviews always took place in the home.
Interviewers were not blind about child’s status as
blinding is practically infeasible in similar studies on
childhood neoplasms. They were instructed (see later)
in order to avoid any differences when contacting case
or control families. A consensus form was signed before
the interview.
Although we wished to interview both parents at the
same time, we soon realized that this was not always
possible. When appropriate, further information regarding
the non participating parent was provided by the attending
spouse and confirmed or elicited over the phone.
The interviews were conducted according to a stan-
dardized questionnaire and were carried out by specific-
ally trained interviewers. The questionnaire was designed
for a duration of between 1 hour and 1 hour and 30
minutes.
Items included were:
 Personal and medical history, including reproductive
history, pregnancy duration, child conditions at birth,
breast feeding, X-rays, childhood diseases and
immunizations;
 Exposure to chemical substances at home and in the
environment, with focus on solvents, pesticides,
traffic pollution, environmental tobacco smoke;
 Checklist on maternal (during pregnancy) and
child’s home exposure to electrical appliances;
 School attendance, including age at first attendance,
school and class size;
 Parental lifelong occupational history, with detailed
job and workplace description;
 Parental educational level, measured as the highest
level of education attained;
 Child’s lifelong and maternal (during pregnancy)
residential history, with details on all dwellings,
including full addresses, location (urban or rural),
indicators of traffic pollution, pesticide environmental
exposure and proximity to power lines and
broadcasting stations.
Information on parental occupational exposure was
collected using different tools: first a lifelong list of occu-
pations (job title and industrial activity) was gathered with
corresponding dates of commencement and finish. For
each occupation dating from one year before conception
until child’s diagnosis, further details were collected using
job specific modules focused on exposure to solvents,
pesticides and other chemicals. Questions on potential
ionizing radiation exposure and on EMF sources were also
included. Regarding agricultural work, crop-specific
modules were prepared, focussing on pesticides and
insecticides. The questionnaire is available on request.
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ELF-MF was measured by the interviewer in the main
rooms of the house (usually chosen among the living
room, parents’ and child’s bedroom and kitchen), ac-
cording to a defined protocol including measurements
taken in the centre and corners of each room, with lights
and electrical appliances on and off (spot measure-
ments). An ELF-MF meter was left under or close to
child’s bed for a 48 hours measurement (long-time mea-
surements). Two types of portable meters were used:
EMDEX II® for spot measurements and either EMDEX-
Lite® or EMDEX II® for long term measurements. Both
meters take an instantaneous field measurement on
three orthogonal axes at fixed intervals. Sampling inter-
val was set to 4 seconds for spot and to 30 seconds for
long term measurements. In the statistical analyses mea-
surements were summarized according to different met-
rics (arithmetic and geometric means and percentiles).
Instantaneous measurements below the detection limit
(0.01 μT) to compute geometric means were substituted
with the value of 0.0001 μT. All meters were calibrated
in laboratory every 6 months and whenever unexpected
results were observed. All sets of measurements were
inspected graphically using the EMCALC© software
(v.95 and later): defective sets of measurements were
excluded and, if possible, repeated. If repetition was not
feasible, the measurement was truncated. Evaluation was
performed blindly in a laboratory setting by a trained
physicist. The protocol for ELF-MF measurement was
defined during a pilot study including a random sample
of over 100 subjects in 5 regions [11].
The questionnaire included questions on maternal use
of mobile and cordless phones during pregnancy and on
the distance of dwellings from radio towers or mobile
phone stations.
Expert assessment of parental occupational exposure
Occupational exposure to a list of exposures of apriori
interest was estimated with expert assessment of the infor-
mation in the questionnaire and in the job specific mod-
ules. Assessment was performed by a team of industrial
hygienists and was conducted blindly as to the case or con-
trol status. The same procedure was used for both parents.
Interviewer training
Interviewers were trained during a residential course
that took place before the study commencement and
was repeated yearly. The first course edition focused on
the general principles of the epidemiological study, on the
psychological approach to cases’ and controls’ families, on
the questionnaire and on the use of ELF-MF meters.
Subsequent editions were more focused on the discussion
and the analysis of practical work, based on interviewers’
experience.Power and data analysis
The power of the study was estimated on the basis of
the number of cases expected in the study period (696
ALL, 113 AnLL, 78 NHL and 219 neuroblastoma) [9,10].
Regarding leukaemia, the sample size was large enough to
detect moderately increased relative risks as statistically
significant (e.g. RR > =2.8 with 1% of exposed and 1.7 with
5%; α=.05, 1-β=.80).
Study management and data registration were carried
out using Microsoft Access; statistical analyses using
EMCALC® (V.95 and later) (for ELF-MF measurements
data), SAS 9.2 and Stata 10.
Ethical committee
The SETIL study was authorized by the Ethical Review
Board for the Piedmont Region (authorization n. 2886,
on 15/2/1999; letter n. 1852/28.3 on 17/2/1999) and
later by the corresponding board of each participating
research unit.
Results
The study included 14 of the 20 Italians regions, corre-
sponding to 78.3% of the total Italian population in the
0–10 age range (86.9% in Northern Italy, 100% in Central
Italy and 60.8% in Southern Italy). In some regions the
study was limited to limited areas or was conducted for
less than the three year period anticipated according to
the protocol Table 1. Lombardy weighed most in the
study, followed by the Venetian Region (Veneto). For
logistic reasons two research units were active in Sicily,
respectively for the Province of Palermo and for the
eastern part of the region.
In the study period the eligible cases were as follows:
745 children affected by leukaemia, 116 by NHL and
207 by neuroblastoma. One thousand four hundred
seventy five controls were randomly selected and indi-
vidually matched to leukaemia cases. These numbers
excluded the subjects found non eligible during the
study process. Participation was 91.7% for leukaemia,
83.6% for NHL and 74.9% for neuroblastoma cases, and
70.8% for controls. Non participants were not substituted.
Family refusal was the most common reason of non-
participation among controls (70.3% of non participants)
while it was less frequent among non participating cases
(leukaemia: 41.9%, NHL: 31.6%, neuroblastoma: 40.4%).
Denied medical approval, was obviously more frequent
among non-participating cases (leukaemia 45.2%; NHL
36.9%; neuroblastoma 33.7%), than among controls (6.3%).
(Table 1). The relative distribution of participant cases and
controls by region is presented in the additional material
(see Additional file 1: Table S1). All large Italian geograph-
ical areas (North, Centre, South and the Islands) were
included but the coverage was more comprehensive for
the Northern and Central ones.
Table 1 SETIL study: cases and controls eligible in the study and distribution of non participating subjects by reason
of non participation
Controls Leukaemia NHL Neuroblastoma
n % n % n % n %
Total eligible 1,475 - 745 - 116 - 207 -
Participant 1,044 70.8% 683 91.7% 97 83.6% 155 74.9%
Non participant 431 29.2% 63 8.3% 19 16.4% 52 25.1%
Reason for non participation
Family refusal 303 70.3% 26 41.3% 6 31.6% 21 40.4%
Medical refusal 27 6.2% 7 11.1% 3 15.8% 6 11.1%
Dying child, medical consensus not obtained 0 0.0% 21 33.3% 4 21.1% 11 21.1%
Adopted, no information on natural family 4 0.9% 2 3.2% 1 5.3% 0 0.0%
Untraced or not approached 94 21.8% 6 9.5% 1 5.3% 8 15.4%
Other and unknown 3 0.7% 0 0.0% 4 21.1% 6 11.5%
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majority of 683 leukaemia cases participant in the study
were of the Acute Lymphoblastic Leukaemia (ALL)
subtype (594 cases, 87%), with 7 cases of Acute Hybrid
Leukaemia (included in the AnLL group for simplicity),
and 82 cases (13%) of Acute non Lymphoblastic Leukaemia
(AnLL). Frequency distribution of AnLL by cytological
subtype was: M1: 7.3%, M1-M2: 14.6%, M2: 15.9%, M3:
19.5%, M4: 12.2%, M5: 17.1%, M6: 1.2%, M7: 2.4, other
and unclassified: 9.8%.
Table 2 presents the distribution of participating sub-
jects by selected characteristics. The attained educational
level was higher among controls than cases. The level of
education among controls was: primary education for
44.3% of fathers and 38.3% of mothers; secondary for
40.6% and 48.2% and tertiary for 14.5% and 13.3%. The
time lag between diagnosis or pseudo diagnosis and
interview was shorter for cases, especially for leukaemia,
than for controls: cumulative proportions of interview at
18 months from diagnosis were 75.8% for leukaemia,
54.9% for controls, 55.7% for NHL and 55.5% for neuro-
blastoma cases.
Parents’ participation was recorded separately for each
section of the interview. Overall, mothers attended the
interview more often, with participation in the range
98.2% of interviews (section on dwellings) to 99.0%
(maternal occupation), while fathers’ participation was in
the range 62.5% (section on dwellings) to 69.5% (section
on general information). Additional information on occu-
pation was provided at a later time by 4% of fathers. No
differences were observed for maternal participation by
case/control status while limited differences were observed
for paternal participation, that was lower for controls and
also for lymphoma cases (Additional file 1: Table S2).
The participation to ELF-MF long term measurements
is summarized in the supplementary material (Additionalfile 1: Tables S3). The overall proportion of eligible
subjects with measurement is lower for controls (61%)
and highest for the leukaemia cases (82%), depending
on the participation in the interview: among those who
accepted it, the proportion without measurements is
similar in the cases and controls.
Prevalence of infectious diseases until reference time are
summarized in Table 3. Chickenpox was reported for
35.0% of controls, followed by mumps (11.4%). For all dis-
eases included in the checklist, in most instances the diag-
nosis was reported as “confirmed by a medical doctor”.
High temperature and illness affecting the upper airways
(colds, throat infections, sinusitis, ear infections…) in the
first year of life were reported by 62.5% of controls, with
medical confirmation in 93.1%. More serious diseases of
likely infectious origin, such as bronchitis (16%) or pneu-
monia (0.8%) were much rarer.
Parental smoking habits were considered focussing
on the year of conception for the father and on the
pregnancy for the mother (Table 4): two different indi-
cators were used to summarize questionnaire information:
for fathers cigarettes/day during the year of conception
and for mothers the cumulative number of packs summed
over the pregnancy. Over a quarter of controls’ fathers
reported smoking over 10 cigarettes/day during the
year of conception: the proportion varied according to
education (a higher smoking prevalence was observed
among the less educated) and region (North to South
increasing gradient). Maternal smoking was less com-
mon (71.4% non smokers, 25% in the category up to
100 packs and 3.2% in the category over 100 packs as
cumulative consumption during pregnancy) and their
level of education appeared to have a smaller impact
(higher smoking prevalence among the less educated)
and region (higher smoking prevalence in Central Italy
regions).
Table 2 SETIL study: frequency distribution of participating subjects by condition, gender, child’s age, year of
diagnosis, lag between diagnosis and interview (months), parental education level, maternal age at child’s birth
Controls Leukaemia NHL Neuroblastoma
n % n % n % n %
Gender Girls 482 46.2 313 45.8 19 19.6 63 40.6
Boys 562 53.8 370 54.2 78 80.4 92 59.4
Total 1044 100.0 683 100.0 97 100.0 155 100.0
Age [0; 2) 156 14.9 95 13.9 5 5.2 88 56.8
[2; 4) 351 33.6 243 35.6 10 10.3 33 21.3
[4; 6) 233 22.3 146 21.4 14 14.4 25 16.1
[6; 11) 304 29.1 199 29.1 68 70.1 9 5.8
Year of diagnosis 1998 109 10.4 67 9.8 7 7.2 20 12.9
1999 314 30.1 212 31.0 32 33.0 35 22.6
2000 342 32.8 229 33.5 32 33.0 57 36.8
2001 279 26.7 175 25.6 26 26.8 43 27.7
Lag diagnosis - interview (months) [0; 6) 30 2.9 29 4.2 5 5.2 5 3.2
[6; 12) 170 16.3 192 28.1 21 21.6 30 19.4
[12; 18) 373 35.7 297 43.5 28 28.9 51 32.9
[18 and over] 471 45.1 165 24.2 43 44.3 69 44.5
Maternal education Primary 400 38.3 320 46.9 43 44.3 66 42.6
High school 503 48.2 285 41.7 44 45.4 75 48.4
University d. 139 13.3 78 11.4 10 10.3 14 9.0
Missing data 0 0.0 0 0.0 0 0.0 0 0.0
Paternal education Primary 463 44.3 340 49.8 47 48.5 81 52.3
High school 424 40.6 268 39.2 39 40.2 57 36.8
University d. 151 14.5 70 10.2 11 11.3 16 10.3
Missing data 6 0.6 5 0.7 0 0.0 1 0.6
Maternal age at child’s birth Mean (SD) 29.66 (4.76) 29.84 (4.91) 29.84 (4.86) 30.10 (4.75)
Paternal age at child’s birth Mean (SD) 33.95 (5.40) 33.13 (5.61) 32.66 (5.27) 33.79 (5.52)
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31.2% of controls, with 9.4% in the highest category of 4
hours of exposure per day (Table 5). Child’s passive smoking
was summarized in a cumulative index counting a number
of cigarettes up to the reference date, considering all sources
(most notably parents and relatives). Exposure to passive
smoking was reported for 28.6% of controls, with 11.4% in
the highest category of over 7000 cigarettes (Table 5). For
both maternal and child’s passive smoking the trends were
as for active parental smoking: higher exposure among the
less educated and North to South increasing gradient.
Table 6 presents exposure ELF-MF, according to the
results of long term ELF-MF measurements. Results
were summarized according to the following metrics:
arithmetic and geometric mean, median and 90° and 95°
percentile, grouped in four classes (<0.1, 0.1-0.2, 0.2-0.3
and over 0.3 μT). Data from the arithmetic mean
showed 8.8% of controls were exposed at over 0.1 μT,
3.5% at over 0.2 μT and 2.1% at over 0.3 μT.The distribution of controls’ parents according to job
description and condition from one year before concep-
tion to the child’s diagnosis is presented in the supple-
mentary material (Additional file 1: Table S4 and S5,
respectively). Almost all fathers of control children were
employed at the study time: only 1.3% described them-
selves as “never employed”. On the contrary 13.3% of
mothers reported themselves as “never employed”, with
large regional variations.
Occupational exposure to solvents (at any time from one
year before conception until child’s diagnosis) was observed
for 18.3% of controls’ fathers and 7.7% of controls’ mothers
(Table 7). Corresponding proportions of exposed to ben-
zene were 3.3% and 0.3%. Contact with public was more
frequent among mothers (36.1%) than fathers (23.4%).
Discussion
This paper presents methods and summarizes descrip-
tive results of the SETIL Italian case–control study on
Table 3 SETIL study: prevalence of common infections among controls
Yes Missing MD confirmation
N % N % N %
At any time before reference date Measles 62 5.9 5 0.5 61 98.4
Pertussis 67 6.4 4 0.4 65 97.0
Rubella 49 4.7 6 0.6 44 89.8
Chicken pox 365 35.0 1 0.1 355 97.3
Mumps 119 11.4 5 0.5 113 95.0
Scarlet fever 80 7.7 6 0.6 78 97.5
Mononucleosis 12 1.2 3 0.3 11 91.7
Herpes Labialis 25 2.4 1 0.1 15 60.0
Herpes Oral mucosae 44 4.2 2 0.2 38 86.4
First year of life. Febrile diseases - respiratory tract 653 62.6 9 0.9 608 93.1
Bronchitis 167 16.0 5 0.5 165 98.8
Pneumonia 8 0.8 6 0.6 8 100.0
G.U. infections 43 4.1 6 0.6 42 97.7
Febrile diseases - unspecified 46 4.4 9 0.9 36 78.3
Percentages are computed over the number of participant controls.
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provides a first description of the extent of exposure of
Italian children in pre-school and primary school age to
some putative risk factors for leukaemia.
Distribution of cases by age and gender was very close
to expectations according to the population cancer regis-







N % N % N
Total 571 55.3 188 18.2 273
Education Less than high school 211 45.8 80 17.3 170
High school 253 60.2 80 19.1 87
University 107 71.3 27 18.0 16
Missing 0 1 0
Residence North. Italy (excl. Lombardy) 155 62.5 40 16.1 53
Lombardy 146 57.3 50 19.6 59
Central Italy 140 55.3 47 18.6 66
Southern Italy 130 47.1 51 18.5 95
Paternal smoking is referred at child conception and maternal smoking during preg
Percentages are calculated by row, on subjects with available information.
aNonsmoker category includes never smokers and fathers who quitted smoking at
bModerate smoker category includes fathers who quitted smoking in the year of th
the conception.
cHeavy smoker category includes fathers that smoked 11 or more cigarettes per da
dNonsmoker category includes never smokers and mothers who quitted smoking a
eModerate smoker category includes mothers who quitted smoking in the year of t
the pregnancy.
fHeavy smoker category includes mothers that smoked 101 or more packets of cigaParticipation in the study was almost complete for leu-
kaemia cases and over 80% for lymphoma and neuroblast-
oma cases. The difference is likely to depend on the longer
time requested for the therapy and the larger proportion
of children that were not in remission. Attending clini-
cians recommended not to contact cases’ families until the









% N N % N % N % N N
26.5 12 745 71.4 265 25.4 33 3.2 1 1044
36.9 2 275 67.9 115 28.4 15 3.7 0 405
20.7 4 372 74.4 114 22.8 14 2.8 1 501
10.7 1 96 70.6 36 26.5 4 2.9 0 136
5 2 0 0 0 2
21.4 2 186 74.4 56 22.4 8 3.2 250
23.1 5 190 73.4 60 23.2 9 3.5 1 260
26.1 4 171 66.5 82 31.9 4 1.6 257
34.4 1 198 71.5 67 24.2 12 4.3 277
nancy.
least the year before conception.
e conception and smokers of 1–10 cigarettes per day in the period of
y in the period of the conception.
t least the year before the pregnancy.
he pregnancy and women that smoked 1–100 packets of cigarettes during
rettes during the pregnancy.
Table 5 SETIL study prevalence of exposure to passive smoking among controls: maternal exposure during pregnancy and child’s exposure to environmental
tobacco smoke, by child’s age, residence, and parental educational level
Maternal exposure to environmental tobacco smoke during pregnancy
Not exposeda <2.00 hours/daya 2.00-3.99 hours/daya ≥4.00 hours/daya Missing TOTAL
N % N % N % N % N N
Total 710 68.8 122 11.8 103 10.0 97 9.4 12 1044
Education (Mother) Less than high school 249 62.4 48 12.0 55 13.8 47 11.8 6 405
High school 349 70.4 66 13.3 35 7.1 46 9.3 5 501
University 110 81.5 8 5.9 13 9.6 4 3.0 1 136
Missing 2 0 0 0 0 2
Residence Northern Italy (excl. Lombardy) 180 72.6 28 11.3 18 7.3 22 8.9 2 250
Lombardy 199 77.1 20 7.8 18 7.0 21 8.1 2 260
Central Italy 179 70.7 22 8.7 26 10.3 26 10.3 4 257
Southern Italy 152 55.7 52 19.0 41 15.0 28 10.3 4 277
Exposure of children to environmental tobacco smoke (as total number of cigarettes)
Not exposeda <1000 cigarettesa 1000-6999 cigarettesa ≥7000 cigarettesa Missing Total
N % N % N % N % N N
Total 740 71.4 91 8.8 88 8.5 118 11.4 7 1044
Age [0–2) 119 76.8 19 12.3 15 9.7 2 1.3 1 156
[2–4) 255 73.1 41 11.7 25 7.2 28 8.0 2 351
[4–6) 161 69.1 24 10.3 13 5.6 35 15.0 0 233
[6–11) 205 68.3 7 2.3 35 11.7 53 17.7 4 304
Education (Both parents) Both parents less than high school degree 283 61.1 52 11.2 51 11.0 77 16.6 3 466
At least one high school degree 337 79.5 29 6.8 25 5.9 33 7.8 3 427
At least one university degree 120 80.0 10 6.7 12 8.0 8 5.3 1 151
Missing 0 0 0 0
Residence Northern Italy (excl. Lombardy) 186 75.0 20 8.1 18 7.3 24 9.7 2 250
Lombardy 211 81.1 22 8.5 11 4.2 16 6.1 0 260
Central Italy 197 77.6 10 3.9 21 8.3 26 10.2 3 257
Southern Italy 146 53.1 39 14.2 38 13.8 52 18.9 2 277
Percentages are calculated by row. Information on maternal exposure missing for 15 controls.












Table 6 SETIL study prevalence of exposure to ELF-MF
among controls (Total n.: 904 with ELF-MF measurements)
Results of ELF-MF measurements (μT)
<=0.1 (0.1 - 0.2] (0.2 - 0.3] >0.3
Metric N % N % N % N %
Arithmetic mean 824 91.15 48 5.31 13 1.44 19 2.10
Geometric mean 837 92.58 43 4.76 11 1.22 13 1.44
Median 842 93.14 36 3.98 11 1.22 15 1.66
90° percentile 754 83.41 91 10.07 19 2.10 40 4.42
95° percentile 721 79.76 112 12.39 27 2.99 44 4.86
99° percentile 659 72.90 126 13.94 53 5.86 66 7.30
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ters and therefore participation rate could be accurately
measured. Case names were selected in the same data base
used for sampling controls, to check the correspondence
between case and control sources, and were always found.
Participation of controls’ families reached 70.8%, a figure
that is similar or higher than the results observed in other
studies on the topic with population based recruitment.
Linet et al. [13] obtained an interview from 72.8% of
controls and a ELF-MF measurement from 63%. In the
UK study [14] participation of controls was 64%, while
it was 62.0% in the German study by Schuz et al. [15].Table 7 SETIL study prevalence of occupational exposure
of among control’s parents
EXPOSURE FATHER MOTHER
N % N %
Any solvent 189 18.3 80 7.7
- Aromatic hydrocarbons 98 9.5 18 1.7
- Chlorinated hydrocarbons 61 5.6 33 3.2
- Technical hydrocarbons 92 8.9 17 1.6
- Aliphatic hydrocarbons 69 6.7 13 1.2
- Derivate oxygenate hydrocarbons 75 7.2 45 4.3
Benzene 34 3.3 3 0.3
Chloroform 2 0.2 0 0
Dichloromethane 14 1.3 15 1.4
Dioxane 1 0.1 0 0
Styrene 9 0.9 3 0.3
Tetracloroethane 25 2.4 5 0.5
Trichloroethylene 27 2.6 8 0.8
1,1,1 trichloroethane 15 1.4 1 0.1
Toluene 73 7.0 12 1.1
Xylene 69 6.6 10 1.0
Acetamide 0 0 0 0
Acrylonitrile 7 0.7 0 0
P. aminoazobenzene 0 0 1 0.1
Percentages are computed over the number of participant controls.Ma et al. observed in California that control participa-
tion was 78.2% of those who accepted a first contact
with the study [16], corresponding to an estimated
fraction of 49% of those eligible.
Participant control parents’ education was comparable
to figures provided by the Italian National Institute of
Statistics (ISTAT) for the general population of a corre-
sponding age. In the 2001 census, the proportion of
subjects with high school diploma or university degree
in age class 19–34 was 50.1% for men and 57.9% for
women [17]. With reference to 2004–2005 period figures
were also available for University and High school de-
gree, separately. The proportion of men with University
degrees or Tertiary Education was: 2.8% in the 20–24
age group, 11.6% in the 25–25 age group, 13.5%, in the
30–34 age group, and 12.2%, in the 35–39 age group.
Corresponding proportions with high school diploma
were: 67.5% in the 20–24 age group, 43.8% in the 25–29
age group, 37.8% in the 30–34 age group and 34.0% in
the 35–39 age group. In women the proportion with a
University Degree was: age 20–24: 3.9%, age 25–29:
14.2%, age 30–34: 17.2%, age 35–39: 12.3%; corresponding
proportions with high school diploma were: age 20–24:
69.0%, age 25–29: 50.9%, age 30–34: 40.5%, age 35–39:
34.1%. [18].
The database of ELF-MF measurements included 904
controls, corresponding to an overall participation of
61.1%. Almost 90% of the interviewed subjects also par-
ticipated in the ELF-MF measurements. To our know-
ledge, this is the largest Italian database on long term
measurements of ELF-MF exposure in the general popu-
lation and will be valuable for additional analyses on
ELF-MF exposure by region and by other covariates,
such as socioeconomic variables. The proportion of
controls with estimated exposure to ELF-MF over 0.3 μT
was 1.44% (Geometric mean; 95% CI 0.84% - 2.45%) in
the present study, higher than, but not incompatible
with the proportion of controls living in dwellings with
long term measured ELF magnetic fields above 0.3 μT
observed in the European studies included in the pooled
analyses by Greenland et al. [19], Ahlbom et al. [20],
and Kheifets et al. [21]. The difference is sensitive to the
metric used to summarize the individual measures,
therefore we decided to present results according to
different metrics: in the studies included in the Greenland
et al. [19] pooled analysis, the proportion of controls living
in dwellings with ELF-MF higher than 0.3 μT (summa-
rized using the arithmetic mean) was estimated in 1.33%,
while in the present study the corresponding proportion
was 2.10% (95% CI: 1.35% - 3.26%). If all studies with
measured fields in those pooled analyses are consid-
ered, the proportion of controls exposed to over 0.3 μT
increased to 1.9% (our computation from tabulated
data), because of the larger proportions of controls in
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non-European studies.
In our study we focused on paternal smoking at the
conception and on maternal smoking during pregnancy:
55.3% of controls fathers and 71.4% of mothers stated at
the interview they were non smokers while 44.7% and
28.5% described themselves as smokers. These figures
are close to reports from Italian surveys on correspond-
ing periods. Sardu et al. [22] estimated the proportion of
smokers by age group, gender and period, based on a
national survey from ISTAT: in 1995 (centre of the year-
of-birth distribution in our study) prevalence of smokers
in men was 43% in age 20–24, 47% in age 25–29 and
45% in age to 30–35. Corresponding figures in women
were 24%, 30% and 32%, close to our results. A trend
was observed in education levels, more marked in men
but also present in women. In the 2000 survey on smoking
habits in Italy, Federico et al. [23] observed that in the
25–49 age group smoking prevalence was higher in the
lower education group, both in men (OR of smoking
in lower vs higher education: 1.71) and in women (OR:
1.12). In our study heavy smokers (defined as regular
smokers of 11 or more cigarettes/day) were 26.5% of
fathers and 3.2% of mothers: these figures were lower
than those measured in a survey on smoking in Italian
men and women in 2001, that reported an average 18.8
cigarettes per day in men and 12.2 in women [24]. How-
ever the difference may depend on a protective attitude
of parents, who in spite of not stopping are likely to
reduce the amount smoked, as was observed in studies
on mortality by marital status and parenthood [25,26].
The same study also observed a lower prevalence in the
North of Italy [24], corresponding to our results.
Compared to results on smoking exposure reported in
recent international studies, our results shows similar
prevalence of smokers among fathers and lower preva-
lence among mothers. The study carried out in France
by Rudant et al. [27] investigated a European population
with smoking habits not very different from Italian
population: 5.6% of control mothers reported 10 or more
cigarettes/day during pregnancy. The period considered
for fathers (from birth to interview) is different from the
one considered in our study, nevertheless it is of interest
that 34.0% of fathers reported 10 or more cigarettes/day.
In the study carried out in Canada by MacArthur et al.
[28] prevalence of smoking (10 or more cigarettes per day)
in pregnancy among controls was 21.6% for mothers,
while and 40.6% of fathers of controls reported smoking
before index child pregnancy. Lee et al. [29] in Korea
reported that 80.4% of (hospital) controls’ fathers smoked
in the year of child’s pregnancy. In Milne et al. [30] study,
12.3% of mothers of controls reported having smoked 15
or more cigarettes /day during pregnancy and 19.6% of
fathers reported having smoked 15 or more cigarettes/day in the year of conception. The association of
parental smoking and leukemia in the SETIL study was
addressed by Mattioli et al. [31] for AnLL and by Farioli
et al. [32] for ALL.
The SETIL study investigated occupational exposure
to chemical substances and other agents using the expert
assessment procedure. Results on solvents exposure
were presented elsewhere [33]. Although such a proced-
ure has been frequently used in occupational studies on
adult cancer since the 80’s [34], its application in the
investigation on parental exposure and childhood cancer
has been limited so far. The different methodology in
evaluating parental exposure and the different informa-
tion provided in reports are serious limits in comparing
the prevalence of exposure of controls across different
studies and therefore only limited comparisons can be
carried on. Solvent exposure was evaluated in different
studies but only a few provided information useful for
estimating parental prevalence of exposure: Bukley et al.
[35] using self reported information evaluated that
61/178 controls had paternal solvent exposure and that
in 23.6% (42/178) such exposure had lasted over 1000
days. Schuz et al. [36] estimated the prevalence of pater-
nal and maternal exposure to solvents at any time before
interview in 12.9% (382/2962) controls and in 5.0 (147/
2962) of controls, respectively. Reid et al. [37] estimated
the prevalence of paternal and maternal exposure to sol-
vents at any time before child birth in 51% (382/748)
controls and in 13% (114/854) of controls, respectively.
Corresponding prevalence one year before birth was 25%
(189/748) and 4% (31/854), respectively. In our study
and considering controls, experts assigned exposure to
solvents to 18.3% of fathers and 7% of mothers.Conclusions
Our results showed that the exposure of Italian children
to cancer risk factors is not negligible, consistently with
other countries of Western life style and industrial econ-
omy. Even if the association of common risk factors such
as smoking with childhood leukemia is debated, they
clearly represent risk factors for other diseases in child-
hood, such as asthma and acute respiratory illnesses.
SETIL study results on prevalence of exposure indicate
the need to take a stronger stance to reduce it, as it dir-
ectly concern a large proportion of parents and indirectly
affect their children.
Large size population based case control studies are a
major resource for providing information on prevalence
of exposure, as shown in this report. The Italian case–con-
trol study on childhood leukaemia, NHL and neuroblast-
oma (SETIL study) represents a useful source of data to
estimate the prevalence of exposure of Italian children to
a broad array of potential carcinogenic factors.
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